Princeton Capital Management LLC Atara Biotherapeutics, Inc. Transaction History

Princeton Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $1,876 - $3,936	-400 Reduced 3.43%	11,256 $88,000
Q4 2021 Feb 09, 2022	SELL	$14.7 - $19.89 $6,394 - $8,652	-435 Reduced 3.6%	11,656 $184,000
Q3 2021 Nov 10, 2021	BUY	$11.99 - $17.9 $5,623 - $8,395	469 Added 4.04%	12,091 $216,000
Q2 2021 Aug 11, 2021	BUY	$12.89 - $16.58 $7,708 - $9,914	598 Added 5.42%	11,622 $181,000
Q4 2020 Feb 11, 2021	SELL	$12.67 - $26.23 $32,245 - $66,755	-2,545 Reduced 18.76%	11,024 $216,000

Q2 2020 Aug 10, 2020	BUY	$7.53 - $14.93 $102,174 - $202,585	13,569 New	13,569 $198,000
Q4 2019 Feb 12, 2020	SELL	$10.89 - $16.79 $49,222 - $75,890	-4,520 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $26,466 - $43,868	2,200 Added 94.83%	4,520 $64,000
Q2 2019 Aug 12, 2019	BUY	$19.05 - $41.04 $44,196 - $95,212	2,320 New	2,320 $47,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.